Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Uses of shh signaling pathway inhibitors

A product and body technology, which can be used in medical preparations, pharmaceutical formulations, and drug combinations containing active ingredients, and can solve problems such as non-inhibition of cell proliferation.

Inactive Publication Date: 2019-10-11
CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Vismodegib inhibits growth, but not cell proliferation, of primary pancreatic xenografts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Uses of shh signaling pathway inhibitors
  • Uses of shh signaling pathway inhibitors
  • Uses of shh signaling pathway inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1, Vil-Cre:Pkd2 f3 / f3 Construction and identification of mouse models

[0043] Vil-Cre:Pkd2 f3 / f3 The mouse is a mouse model that can conditionally knock out Pkd2 established by using the Cre-loxP system, which can produce a clinical phenotype similar to that of human autosomal dominant polycystic kidney disease (Autosomal Dominant Polycystic Kidney Disease, ADPKD) and die early. For renal failure, it can be used as an animal model of ADPKD. Its construction and identification process is as follows:

[0044] 1. Vil-Cre:Pkd2 f3 / f3 Construction of mouse model

[0045] Pkd2 f3 / f3 The mouse was crossed with the transgenic mouse (B6.SJL-Tg(Vil-cre)997Gum / J) with Vil-Cre recombinase to obtain the F1 generation (theoretically, 1 / 2 of the offspring's genotype is Vil-Cre :Pkd2 + / f3 ; 1 / 2 offspring are genotyped as Pkd2 + / f3 ); Vil-Cre:Pkd2 in the F1 generation + / f3 Mice (PCR identification for the Cre gene, see below for the specific method, the F1 generation...

Embodiment 2

[0053] Example 2, the application of Vismodegib in the treatment of autosomal dominant polycystic kidney disease

[0054] In this embodiment, Vil-Cre:Pkd2 f3 / f3 Mice are used as animal models of ADPKD to study and analyze the application of Vismodegib in the treatment of autosomal dominant polycystic kidney disease. details as follows:

[0055] 1. Experimental method

[0056] 1. Experimental grouping and processing

[0057] Vismodegib solution: Dissolve Vismodegib in DMSO to a concentration of 80 mg / mL, then dilute to 2 mg / ml with normal saline.

[0058] Grouping and treatment: Divided into treatment group and control group, 10 Vil-Cre:Pkd2 in each group f3 / f3 mice. From the tenth day after the mice were born, subcutaneous injections were carried out for a week, and then changed into intraperitoneal injections, and the drug was withdrawn every day until the mice were two months old. Vismodegib) dosage administration; control group injects equal volume of normal saline co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses new uses of a Shh signaling pathway inhibitor. The new uses of the Shh signaling pathway inhibitor specifically comprises applications of the Shh signaling pathway inhibitor in preparation of autosomal domi-nant polycystic kidney disease (ADPKD) treatment product, wherein the Shh signaling pathway inhibitor is specifically Vismodegib. According to the present invention, a Vil-Cre:Pkd2f3 / f3 mouse as an ADPKD animal model, and the results show that with the Shh signaling pathway inhibitor Vismodegib, the renal cyst degree of the Vil-Cre:Pkd2f3 / f3 mouse can be reduced, the kidney weight ration of the Vil-Cre:Pkd2f3 / f3 mouse can be reduced, the contents of creatinine and urea nitrogen in the blood of the Vil-Cre:Pkd2f3 / f3 mouse can be reduced, and the renal fibrosis degree of the Vil-Cre:Pkd2f3 / f3 mouse can be reduced; and the important significance is provided for the analysis of the ADPKD pathogenesis and the research and development of the ADPKD treatment drug.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a new application of a Shh (sonic hedgehog) signal pathway inhibitor, in particular to the application of an Shh signal pathway inhibitor—Vismodegib in the treatment of autosomal dominant hereditary polycystic kidney disease. Background technique [0002] Vismodegib is a new oral drug with selective Hedgehog signaling pathway inhibition, which has been approved by the FDA for the treatment of basal cell carcinoma. [0003] Vismodegib effectively inhibits the hedgehog pathway and is a novel and specific synthetic small molecule inhibitor with IC50 of 3nM. Vismodegib acts on the Hedgehog signaling pathway, blocking the Hedgehog ligands, that is, the activity of cell surface receptors PTCH and SMO, thereby blocking the Hedgehog signaling pathway. In terms of tissue growth and repair, the Hedgehog signaling pathway is of great significance. Abnormal activation of Hedgehog pathway signaling ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4418A61P13/12
Inventor 吴冠青李奥
Owner CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com